Scientists Fine-Tune emergency bleeding drug in healthy volunteers
NCT ID NCT07312851
Summary
This early-stage study aims to better understand how andexanet, a drug used to reverse the effects of certain blood thinners in emergencies, works and when it's safe to give another blood thinner (enoxaparin) afterward. It involves 186 healthy participants and will measure how the drugs affect blood clotting. The goal is to gather data to help doctors use these medications more safely and effectively in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGBerlin, 14050, Germany
-
Research Site
RECRUITINGHarrow, HA1 3UJ, United Kingdom
Conditions
Explore the condition pages connected to this study.